MQS Management LLC Invests $59,000 in Aveanna Healthcare Holdings Inc. $AVAH

MQS Management LLC purchased a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 11,197 shares of the company’s stock, valued at approximately $59,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Summit Partners L P purchased a new stake in Aveanna Healthcare in the second quarter valued at approximately $50,477,000. Strs Ohio purchased a new stake in Aveanna Healthcare in the first quarter valued at approximately $218,000. Teacher Retirement System of Texas grew its holdings in Aveanna Healthcare by 50.9% in the first quarter. Teacher Retirement System of Texas now owns 49,881 shares of the company’s stock valued at $270,000 after purchasing an additional 16,835 shares during the period. Diversified Trust Co purchased a new stake in Aveanna Healthcare in the second quarter valued at approximately $57,000. Finally, MetLife Investment Management LLC grew its holdings in Aveanna Healthcare by 16.2% in the first quarter. MetLife Investment Management LLC now owns 31,251 shares of the company’s stock valued at $169,000 after purchasing an additional 4,349 shares during the period. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder Paul R. Vigano sold 10,000,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 21st. The stock was sold at an average price of $9.00, for a total transaction of $90,000,000.00. Following the completion of the sale, the insider owned 386,284 shares in the company, valued at $3,476,556. This trade represents a 96.28% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder J.H. Whitney Equity Partners V sold 8,346,059 shares of the firm’s stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total value of $75,114,531.00. Following the sale, the insider owned 20,544,696 shares of the company’s stock, valued at approximately $184,902,264. This trade represents a 28.89% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 32,597,968 shares of company stock valued at $293,381,712. Corporate insiders own 7.00% of the company’s stock.

Aveanna Healthcare Stock Up 1.9%

Shares of AVAH stock opened at $9.81 on Wednesday. The firm’s 50 day moving average price is $8.60 and its two-hundred day moving average price is $6.24. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $3.67 and a fifty-two week high of $10.32. The stock has a market cap of $2.05 billion, a price-to-earnings ratio of 122.63 and a beta of 2.05.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. Aveanna Healthcare had a net margin of 0.85% and a negative return on equity of 54.56%. The business had revenue of $450.53 million for the quarter. On average, equities analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on AVAH. Raymond James Financial upgraded shares of Aveanna Healthcare from a “market perform” rating to an “outperform” rating and set a $9.00 target price for the company in a report on Monday, August 11th. Barclays upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $5.50 to $9.50 in a report on Tuesday, August 19th. JPMorgan Chase & Co. raised shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and lifted their price target for the company from $6.00 to $10.00 in a research report on Thursday, September 18th. Zacks Research cut shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 20th. Finally, UBS Group lifted their price target on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the company a “neutral” rating in a research report on Monday, October 13th. Three analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, Aveanna Healthcare currently has a consensus rating of “Hold” and an average target price of $9.29.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.